Predictive Disease Analytics Market Research Report Information By Component (Software & Services and Hardware), By Deployment (On-premise and Cloud-based), By End User (Healthcare Payers, Healthcare Providers, and Other End Users), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT

6.1. Overview

6.2. Software & Services

6.3. Hardware

7. GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT

7.1. Overview

7.2. On-premise

7.3. Cloud-based

8. GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER

8.1. Overview

8.2. Healthcare Payers

8.3. Healthcare Providers

8.4. Other End Users

9. GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, BY REGION

9.1. Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. U.K

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. China

9.4.2. India

9.4.3. Japan

9.4.4. South Korea

9.4.5. Australia

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Predictive disease analytics Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Predictive disease analytics Market,

10.7. Key developments and Growth Strategies

10.7.1. New Component Launch/Deployment Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Oracle

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Components Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. IBM

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Components Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. SAS

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Components Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Allscripts Healthcare Solutions Inc.

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Components Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. MedeAnalytics, Inc.

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Components Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. HEALTH CATALYST.

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Components Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Apixio Inc.

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Components Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 9 NORTH AMERICA PREDICTIVE DISEASE ANALYTICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 10 U.S. PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 11 U.S. PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 12 U.S. PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 13 CANADA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 14 CANADA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 15 CANADA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 16 EUROPE PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 17 EUROPE PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 18 EUROPE PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 19 EUROPE PREDICTIVE DISEASE ANALYTICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 20 GERMANY PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 21 GERMANY PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 22 GERMANY PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 23 FRANCE PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 24 FRANCE PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 25 FRANCE PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 26 ITALY PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 27 ITALY PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 28 ITALY PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 29 SPAIN PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 30 SPAIN PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 31 SPAIN PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 32 U.K PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 33 U.K PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 34 U.K PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 35 REST OF EUROPE PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 36 REST OF EUROPE PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 37 REST OF EUROPE PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 38 ASIA PACIFIC PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 39 ASIA PACIFIC PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 40 ASIA PACIFIC PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 41 ASIA PACIFIC PREDICTIVE DISEASE ANALYTICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 42 JAPAN PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 43 JAPAN PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 44 JAPAN PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 45 CHINA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 46 CHINA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 47 CHINA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 48 INDIA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 49 INDIA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 50 INDIA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 51 AUSTRALIA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 52 AUSTRALIA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 53 AUSTRALIA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 54 SOUTH KOREA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 55 SOUTH KOREA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 56 SOUTH KOREA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 57 REST OF ASIA-PACIFIC PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 58 REST OF ASIA-PACIFIC PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 59 REST OF ASIA-PACIFIC PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 60 REST OF WORLD PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 61 REST OF WORLD PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 62 REST OF WORLD PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 63 REST OF WORLD PREDICTIVE DISEASE ANALYTICS MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 64 MIDDLE EAST PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 65 MIDDLE EAST PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 66 MIDDLE EAST PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 67 AFRICA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 68 AFRICA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 69 AFRICA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 70 LATIN AMERICA PREDICTIVE DISEASE ANALYTICS MARKET, BY COMPONENT, 2018-2032 (USD BILLION)

TABLE 71 LATIN AMERICA PREDICTIVE DISEASE ANALYTICS MARKET, BY DEPLOYMENT, 2018-2032 (USD BILLION)

TABLE 72 LATIN AMERICA PREDICTIVE DISEASE ANALYTICS MARKET, BY END USER, 2018-2032 (USD BILLION) 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET

FIGURE 4 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY COMPONENT, 2022

FIGURE 5 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY DEPLOYMENT, 2022

FIGURE 6 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY END USER, 2022

FIGURE 7 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: PREDICTIVE DISEASE ANALYTICS MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL PREDICTIVE DISEASE ANALYTICS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 ORACLE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 ORACLE: SWOT ANALYSIS

FIGURE 15 IBM: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 IBM: SWOT ANALYSIS

FIGURE 17 SAS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 SAS: SWOT ANALYSIS

FIGURE 19 ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 ALLSCRIPTS HEALTHCARE SOLUTIONS INC.: SWOT ANALYSIS

FIGURE 21 MEDEANALYTICS, INC..: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 MEDEANALYTICS, INC..: SWOT ANALYSIS

FIGURE 23 HEALTH CATALYST.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 HEALTH CATALYST.: SWOT ANALYSIS

FIGURE 25 APIXIO INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 APIXIO INC.: SWOT ANALYSIS